Portal — 2024 Investments

4 investments dated 2024 · listed companies and verified rows first · show all

CrossBridge Biocrossbridgebio.comOct 2024

CrossBridge Bio, launched in 2023, develops next-generation antibody-drug conjugates (ADCs) to address a range of cancer indications.

BiotechHealthtechHouston, US

Kyoji Tsuchikama(Executive Officer, Director, Promoter)Michael Torres(Executive Officer, Director, Promoter)

Board William F. McKeon(Director)Damir Illich(Director)Patrick James Crutcher(Director)

Co-investorsPortal Innovations TMC Venture Fund

Hemi Labshemi.xyz in 𝕏Seed · Sep 2024 · $15M

Hemi is a dual-layer Bitcoin protocol that enables smart contract execution and programmability by combining Bitcoin's Proof-of-Work security with Ethereum-level functionality.

Crypto & Web3Data & InfrastructureDeveloper ToolsFintech

Matthew Roszak(Co-Founder, Hemi Labs)Jeff Garzik(Principal Engineering, Hemi Labs)Max Sanchez(Lead Architect, Hemi Labs)

Co-investorsBig Brain Holdings Gate Ventures Hyperchain Capital Impossible Finance Optic Capital TRGC+1 more

Sapiengetsapien.com in 𝕏Seed · Apr 2024 · $5M

Sapien provides analytics software for operations and finance teams to decompose unit economics, trace margin variance to operational drivers, and model sourcing, pricing, and capacity scenarios.

AI & Machine LearningEnterprise SoftwareFintechSaaS

Ron Nachum(Co-founder)in Arya Grayeli(Co-founder)inPranav Ravella(Co-founder)in

Co-investorsFirestreak Ventures FOG Ventures General Catalyst Primitive Ventures Artichoke Capital IVC

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Grantx

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.